---
title: "300039.SZ (300039.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300039.SZ/news.md"
symbol: "300039.SZ"
name: "300039.SZ"
parent: "https://longbridge.com/en/quote/300039.SZ.md"
datetime: "2026-06-25T19:34:11.625Z"
locales:
  - [en](https://longbridge.com/en/quote/300039.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300039.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300039.SZ/news.md)
---

# 300039.SZ (300039.SZ) — Related News

### [SHANGHAI KAIBAO: The controlling shareholder and some directors and senior executives have completed their share buyback, with a total increase of 0.04% of shares](https://longbridge.com/en/news/290546245.md)
*2026-06-23T10:15:29.000Z*
> SHANGHAI KAIBAO announced that the company's controlling shareholder and actual controller Mu Jingwei, director Wang Guo

### [The controlling shareholder, actual controller, and some directors and executives of SHANGHAI KAIBAO plan to increase their holdings in the company's shares](https://longbridge.com/en/news/289595959.md)
*2026-06-12T12:13:03.000Z*
> SHANGHAI KAIBAO announced that the controlling shareholder, actual controller, and some directors and senior management 

### [SHANGHAI KAIBAO: The Shanghai Securities Regulatory Bureau has ordered the company to make corrections and issued warning letters to relevant personnel](https://longbridge.com/en/news/289187770.md)
*2026-06-09T12:15:03.000Z*
> SHANGHAI KAIBAO announced that it received a corrective measure order from the Shanghai Securities Regulatory Bureau and

### [SHANGHAI KAIBAO: Net profit in the first quarter of 2026 was 64.8659 million yuan, a year-on-year decrease of 23.05%](https://longbridge.com/en/news/284210217.md)
*2026-04-27T12:00:07.000Z*
> SHANGHAI KAIBAO announced that its revenue for the first quarter of 2026 was 283 million yuan, a year-on-year decrease o

### ["Haifei Show" or "Ai Qi"? Compliance issues behind the solution controversy](https://longbridge.com/en/news/273965351.md)
*2026-01-28T09:07:28.000Z*
> In the medical beauty industry, changes in agency rights are common, but compliance issues are prominent. In 2025, SHANG

### [SHANGHAI KAIBAO: The company currently has no weight loss drug-related products](https://longbridge.com/en/news/269024385.md)
*2025-12-09T01:58:14.000Z*
> On December 9th, SHANGHAI KAIBAO stated on the interactive platform that the company currently has no weight loss drug-r

### [SHANGHAI KAIBAO: KBZ24020 approved to conduct clinical trials for acute ischemic stroke](https://longbridge.com/en/news/265317626.md)
*2025-11-11T10:43:07.000Z*
> SHANGHAI KAIBAO recently received approval from the National Medical Products Administration to conduct clinical trials 

### [SHANGHAI KAIBAO: Net profit for the third quarter was 65.0877 million yuan, a decrease of 13.13%](https://longbridge.com/en/news/263075551.md)
*2025-10-28T11:52:29.000Z*
> SHANGHAI KAIBAO announced that its revenue for the third quarter was 214 million yuan, a decrease of 26.61%; net profit